AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lairon, D.
Right arrow Articles by Boutron-Ruault, M.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lairon, D.
Right arrow Articles by Boutron-Ruault, M.-C.
Agricola
Right arrow Articles by Lairon, D.
Right arrow Articles by Boutron-Ruault, M.-C.
American Journal of Clinical Nutrition, Vol. 82, No. 6, 1185-1194, December 2005
© 2005 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Dietary fiber intake and risk factors for cardiovascular disease in French adults1,2,3

Denis Lairon, Nathalie Arnault, Sandrine Bertrais, Richard Planells, Enora Clero, Serge Hercberg and Marie-Christine Boutron-Ruault

1 From INSERM, U476, and INRA 1260, Université de la Méditerranée, Marseille, France (DL and RP), and INSERM, U557, and CNAM, ISTNA, Paris, France (NA, SB, EC, SH, and M-CB-R)

2 Supported by Fruit d'Or Recherche, Lipton, Cereal, Candia, Kellogg's, CERIN, LU/Danone, Sodexho, L'Oréal, Estée Lauder, Peugeot, Jet Service, RP Scherer, France Telecom, Becton Dickinson, Fould Springer, Boehringer Diagnostic, Seppic Givaudan Lavirotte, Le Grand Canal, Air Liquide, Carboxyque, Klocke, Trophy Radio, Jouan, and Perkin-Elmer during the establishment and follow-up of the SU.VI.M.AX cohort. Bio-Rad (Vitry-sur-Seine, France) and Carlo Erba France (Val-de-Reuil, France) provided the materials needed to analyze the blood samples.

3 Reprints not available Address correspondence to D Lairon, UMR 476 INSERM/1260 INRA, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France. E-mail: denis.lairon{at}medecine.univ-mrs.fr.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Increased consumption of dietary fiber is widely recommended to maintain or improve health, but knowledge of the relation between dietary fiber sources and cardiovascular disease risk factors is limited.

Objective: We examined the relation between the source or type of dietary fiber intake and cardiovascular disease risk factors in a cohort of adult men and women.

Design: In a cross-sectional study, quintiles of fiber intake were determined from dietary records, separately for 2532 men and 3429 women. Age- and multivariate-controlled logistic models investigated the odds ratios of abnormal markers for quintiles 2-5 of fiber intake compared with the lowest quintile.

Results: The highest total dietary fiber and nonsoluble dietary fiber intakes were associated with a significantly (P < 0.05) lower risk of overweight and elevated waist-to-hip ratio, blood pressure, plasma apolipoprotein (apo) B, apo B:apo A-I, cholesterol, triacylglycerols, and homocysteine. Soluble dietary fiber was less effective. Fiber from cereals was associated with a lower body mass index, blood pressure, and homocysteine concentration; fiber from vegetables with a lower blood pressure and homocysteine concentration; and fiber from fruit with a lower waist-to-hip ratio and blood pressure. Fiber from dried fruit or nuts and seeds was associated with a lower body mass index, waist-to-hip ratio, and fasting apo B and glucose concentrations. Fiber from pulses had no specific effect.

Conclusion: Dietary fiber intake is inversely correlated with several cardiovascular disease risk factors in both sexes, which supports its protective role against cardiovascular disease and recommendations for its increased consumption.

Key Words: Dietary fiber • cardiovascular disease • diabetes • lipids • obesity


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The recent and drastic changes that have occurred in industrialized countries have led to dietary patterns that are based mainly on animal foodstuffs and refined-cereal products and are low in dietary fiber. Nevertheless, as early as the 1970s, Burkitt and Trowell (1) observed major differences in the incidence of several diseases between native and white populations in Africa. Accordingly, the hypothesis was made that a lack of dietary fiber could be involved in the etiology of some Western diseases such as constipation, diverticulosis, cardiovascular disease, and cancers.

During the past decade, numerous key epidemiologic studies relating dietary fiber intake and cardiovascular disease have been published. One of the pioneer studies showed a 4-fold lower death rate from cardiovascular disease in men who ingested high amounts of fiber (≥37 g/d) than in those who ingested the lowest amounts (<20 g/d) (2). More recently, a 6-y prospective study conducted in a large cohort of adult men aged 40–75 y in the United States showed an inverse relation between fiber intake and cardiovascular death rate, with an odds ratio (OR) of 0.6 for a fiber intake of {approx}30 g/d compared with the lowest quintile of intake (10–17 g/d) (3). Similar data have been obtained in other prospective cohort studies conducted in young men in the United States (4) or in European adults (5). In the latter study, a 3-g increase in the daily intake of soluble fiber (SF) was associated with a 27% reduction in cardiovascular disease mortality. A 10-y prospective cohort study performed in a large cohort of women aged 37–64 y in the United States (6) showed that women in the highest fiber intake quintile (22.9 g/d) had a 34% lower risk of coronary heart disease than did those in the lowest quintile (11.5 g/d). This observation was confirmed by other prospective cohort studies in US adult women (7) or men and women (8). A recent meta-analysis of some recent prospective cohort studies confirmed the protective effect of dietary fiber against cardiovascular disease (9).

In most prospective cohort studies, cereal fiber was strongly associated with the observed reductions in cardiovascular events and deaths. This finding is supported by recent data, which showed a protective effect of whole grains (10, 11). However, experimental and clinical studies showed that SF from various sources has mostly metabolic effects (12-15).

In fact, limited epidemiologic data regarding dietary fiber and cardiovascular disease risk factors are available. The aim of our study was thus to investigate the association between risk factors for cardiovascular disease and the different types [total fiber, SF, or nonsoluble fiber (NSF)] and sources (cereal products, legumes, vegetables, fresh fruit, dried fruit or nuts, and seeds) of dietary fiber in a cross sectional study of 5961 subjects included in the French SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants) cohort.


   SUBJECTS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
The subjects were participants in the SU.VI.MAX Study, an ongoing randomized, double-blind, placebo-controlled, primary-prevention trial that was designed to evaluate the effect of daily antioxidant supplementation (vitamin C, vitamin E, ß-carotene, selenium, and zinc) at near-nutritional doses on the incidence of cancer and ischemic heart disease. The design of the study was described elsewhere (16). Briefly, a total of 12 741 eligible subjects (women aged 35–60 y and men aged 45–60 y) were enrolled in 1994–1995 and followed up for 8 y. All subjects were encouraged to provide dietary data in the form of 24-h dietary recalls every 2 mo. For the present study, we elected to include only subjects who had provided at least six 24-h dietary recalls over the first 2 y of the study; we excluded dietary recalls that reported <418 kJ/d (100 kcal/d) or >25 080 kJ/d (6000 kcal/d) and further excluded subjects who had ≥2 of 6 recalls that reported <3344 kJ/d (800 kcal/d) in men and 2090 kJ/d (500 kcal/d) in women. The initial sample included 6634 subjects. We further excluded subjects for whom either anthropometric data or data on physical activity or tobacco intake were missing. The final study sample included 5961 subjects, 2532 men and 3429 women.

The SU.VI.MAX study was approved by the Ethical Committee for Studies with Human Subjects of Paris-Cochin (CCPPRB no. 706) and by the "Commission Nationale Informatique et Liberté" (CNIL no. 334641).

Dietary assessment
The 24-h dietary recalls were provided in a random assessment of 4 weekdays and 2 weekend days per year (17). The subjects transmitted the corresponding data via the Minitel Telematic Network (France Telecom, Paris, France) or Internet, which connected them to the main SU.VI.MAX computer server. They were helped by conversational facilities of the software and by an instruction manual for the codification of food, which included photographs for estimating portion sizes (17). Daily nutrient intakes were calculated from food consumption by using the French computerized CIQUAL food database (18), which was fully updated with data on total dietary fiber and SF (19) based on the measurement method of the Association of Official Analytical Chemists (20). We thus examined the relation between cardiovascular disease risk factors and the following types of dietary fiber: total dietary fiber, SF, NSF (calculated as the difference between total fiber and SF), and total dietary fiber from cereal products, vegetables, pulses, fruit (fresh, canned, or juice), dried fruit, and nuts and seeds.

Anthropometric, clinical, and biological data
Anthropometric and clinical data were recorded during the second year of follow-up, when about one-half of the dietary recalls were obtained. Height, weight, and waist and hip circumferences were measured on subjects in their underwear with the use of standardized procedures. Overweight corresponded to a body mass index (BMI; in kg/m2) of ≥25. The waist-to-hip ratio was considered to be abnormal if ≥0.95 in men or ≥0.80 in women (21). Diastolic and systolic blood pressures were measured once on each arm with the use of a standard mercury sphygmomanometer in subjects who had been lying down for 10 min, and the mean value was recorded. High blood pressure was defined as a systolic blood pressure >140 mm Hg, a diastolic blood pressure >90 mm Hg, or use of antihypertensive medication (n = 350).

Blood samples were collected in Vacutainer tubes (Becton Dickinson, Le Pont de Claix, France) during the first year follow-up (except at year 3 for homocysteine) after the subjects had fasted for ≥12 h. Fasting plasma glucose, total cholesterol, and triacylglycerols were measured by enzymatic methods (Technicon DAX, Tarrytown, NY). Plasma concentrations of apolipoprotein (apo) A-I and apo B were measured by immunonephelometry with the use of specific anti-sera on a BNA autoanalyzer (Behring, Deerfield, IL). Serum concentrations of lipoprotein(a) were measured with an enzyme-linked immunosorbent assay. Plasma homocysteine was measured in a randomly selected subsample of 851 men (plasma samples at year 3) with the use of HPLC and fluorometric detection with a BioRad kit (Hercule SA, Vitry sur Seine, France). Laboratory quality assurance included analysis of serum from standard pools within each run and, if available, international standards.

The biochemical variables were studied in terms of normal compared with abnormal. Acknowledged limits were used for apo A-I, apo B, cholesterol, triacylglycerols, and glucose [1.30 g/L, 1.35 g/L, 6.2 mmol/L (2.40 g/L), 1.7 mmol/L (1.50 g/L), and 7 mmol/L, respectively]. The ratio of apo B to apo A-I was considered to be abnormal if >1.0 (22). The subjects treated for diabetes or high cholesterol were classified as abnormal for fasting glucose or total cholesterol, respectively. Mixed hyperlipidemia was defined as a total cholesterol concentration >2.40 g/L or as the use of medication for the treatment of high cholesterol in combination with a triacylglycerol concentration >1.50 g/L. For total plasma homocysteine (tHcy), we considered a 10 µmol/L limit (23), which provided a sufficient proportion of abnormal values for a high study power.

Statistical analysis
Statistical analyses were carried out by using the SAS (version 8, 1999; SAS Institute Inc, Cary, NC) statistical software package. Quintiles of dietary fiber intake were established separately for each sex. Unconditional logistic regression estimated the OR and 95% CIs of having abnormal values of the studied factor, for each quintile relative to the first quintile of dietary fiber intake. Models were adjusted for sex, age, alcohol-free energy intake, saturated fatty acid intake, carbohydrate intake, tobacco use, alcohol use, and leisure-time exercise. For homocysteine, models also included folate, vitamins B-6 and B12, and coffee consumption. Tests were based on the likelihood ratio test statistic; the importance of main effects was assessed by using the Wald chi-square test statistic, and 2-sided tests and P < 0.05 were used for statistical significance.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
In Table 1Go, the study population is described in terms of biological (obtained during the first year of follow-up, except for homocysteine at the third year) and clinical (obtained during the second year of follow-up) variables and prevalence of risk factors for cardiovascular disease. The prevalence of abnormal markers was much higher in men than in women. In men, the most common findings were high homocysteine (57.4%), cholesterol (50.5%), BMI (51.3%) and blood pressure (42.6%). In women, the most common findings were high cholesterol (37.4%), waist-to-hip ratio (25.6%), and homocysteine (25.3%).


View this table:
[in this window]
[in a new window]
  		TABLE 1 Biological and anthropometric characteristics of French adults from the SU.VI.MAX (SUpplementation in VItamines et Mineraux AntioXdants) cohort1

 
Mean dietary fiber intake by type of fiber (total dietary fiber, SF, or NSF) or dietary source are reported in Table 2Go. Total dietary fiber intake ranged from 4.5 to 64.9 g/d in men with a mean (±SD) intake of 21.9 ± 7.2 g/d and from 2.4 to 65.0 g/d in women with a mean (±SD) intake of 17.9 ± 5.6 g/d. Total dietary fiber intake was mostly composed of NSF: a mean 80.1% in men and 79.9% in women. Most total dietary fiber came from cereal products (37% and 33% in men and women, respectively), vegetables (30.6% and 32.4% in men and women, respectively), and fruit (19.6% and 21.2% in men and women, respectively). The amounts of dietary fiber usually provided by legumes, dried fruit, or nuts and seeds were low.


View this table:
[in this window]
[in a new window]
  		TABLE 2 Fiber intake in French adults from the SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXidants) cohort1

 
Multivariate adjusted ORs and 95% CIs for abnormal values of the studied markers of cardiovascular disease are shown in Tables 3Go and 4Go, by quintile of total dietary fiber, SF, and NSF intakes, respectively; these values were adjusted for sex, age, alcohol-free energy intake, saturated fatty acid intake, carbohydrate intake, tobacco use, alcohol use, leisure-time exercise, and intervention supplement intake.


View this table:
[in this window]
[in a new window]
  		TABLE 3 Odds ratios (and 95% CIs) for the relative risk of abnormal clinical markers of cardiovascular disease by quintile of dietary fiber intake1

 

View this table:
[in this window]
[in a new window]
  		TABLE 4 Odds ratios (and 95% CIs) for the relative risk of abnormal biological markers of cardiovascular disease by quintile of dietary fiber intake1

 
BMI and waist-to-hip ratio were inversely and significantly associated with total dietary fiber or NSF intakes (Table 3Go). A 5-g increase in total dietary fiber resulted in a 10.6% decrease in overweight risk and a 14.7% decrease in risk of high waist-to-hip ratio. Overall, the effects were not significantly different between men and women (data not shown). The only significant interaction was between sex and NSF intake regarding risk of overweight (P for interaction < 0.01). The effect was somewhat stronger in men [OR for quintile 5 versus quintile 1 (ORQ5 versus Q1): 0.60; 95% CI: 0.41, 0.88; P for linear trend = 0.009] than in women (ORQ5 versus Q1: 0.73; 95% CI: 0.50, 1.08; P for trend = 0.18). SF intake was not associated with BMI, whereas it was negatively associated with waist-to-hip ratio (ORQ5 versus Q1: 0.80; 95% CI: 0.63, 1.02; P for trend = 0.03). The risk of high blood pressure was inversely and significantly associated with total dietary fiber intake (ORQ5 versus Q1: 0.71; 95% CI: 0.54, 0.93; P for trend = 0.02) and NSF intake (ORQ5 versus Q1: 0.68; 95% CI: 0.52, 0.89; P for trend = 0.01) but not with intake of SF (P for trend = 0.10). A 5-g increase in total dietary fiber resulted in an 11.6% decrease in high blood pressure risk.

No type of dietary fiber had an effect on apo A-I concentrations (Table 4Go). The risk of a high apo B concentration was significantly and negatively associated with total dietary fiber and NSF intake and borderline significantly associated with SF intake. The ORQ5 versus Q1 values were 0.68 (95% CI: 0.49, 0.95), 0.69 (95% CI: 0.49, 0.95), and 0.79 (95% CI: 0.59, 1.05), respectively. The ratio of apo A-I to apo B decreased mostly by NSF intake. A reduced risk of high cholesterol was associated with high total dietary fiber intake (ORQ5 versus Q1: 0.68; 0.53, 0.87; P for trend = 0.01) and borderline associated with NSF intake (P for trend = 0.06), whereas SF intake had no significant effect. The risk of hypertriacylglycerolemia was negatively associated with total dietary fiber intake (ORQ5 versus Q1: 0.68; 95% CI: 0.48, 0.96; P for trend = 0.01) and NSF intake (ORQ5 versus Q1: 0.65; 95% CI: 0.46, 0.92; P for trend = 0.01), but there was no effect of SF. In contrast, total dietary fiber, SF, and NSF intakes did not significantly affect lipoprotein(a) and fasting glucose concentrations.

A reduced risk of hyperhomocysteinemia was markedly associated with total dietary fiber intake (ORQ5 versus Q1: 0.50; 95% CI: 0.31, 0.82; P for trend = 0.01), NSF intake (ORQ5 versus Q1: 0.52; 95% CI: 0.32, 0.85; P for trend = 0.01), and SF intake (ORQ5 versus Q1: 0.52; 0.34, 0.80; P for trend = 0.005).

The results were not substantially modified when additionally adjusted for BMI; the only significant changes were a slightly decreased effect of total dietary fiber on the ratio of apo A-I to apo B (P for trend = 0.07) and on hypertension (P for trend = 0.06).

Considering that the recommended daily intake of dietary fiber is 25 g (24), the subjects who consumed ≥25 g/d fiber had a lower risk of elevated plasma cholesterol (–7%; P > 0.10), BMI (–19%, P = 0.03), waist-to-hip ratio (–17%; P = 0.06), and hypertension (–26%; P = 0.002) than did consumers of lower amounts of fiber. Overall, an increase of 5 g total dietary fiber/d decreased the risk of high apo B by 9.2%, high homocysteine by 15.4%, overweight by 10.6%, elevated waist-to-hip ratio by 14.7%, and hypertension by 11.6%.

We analyzed correlations between total dietary fiber, SF, or NSF and the whole range of BMI, waist-to-hip ratio, apo A-I, apo B, the apo B:apo A-I, lipoprotein(a), and homocysteine. All correlations were statistically significant (P < 0.001). Correlations were high for waist-to-hip ratio: R2 = 0.60 for all 3 types of dietary fiber. For BMI, the R2 values were 0.18, 0.17, and 0.18 for total dietary fiber, SF, and NSF, respectively. Values were identical for all 3 types of dietary fiber: R2 = 0.14 for apo A-I, 0.15 for apo B, 0.20 for apo B:A-I, 0.10 for homocysteine, and 0.005 for lipoprotein(a).

A significant interaction between the vitamin-mineral intervention supplement and BMI (P for interaction = 0.02) and apo B (P for interaction = 0.01) was observed only for SF. In models stratified on the supplement intake versus no supplement intake, an inverse association was observed between BMI and SF only in the supplemented group (ORQ5 versus Q1: 0.80; 95% CI: 0.57, 1.12; P for trend = 0.03), whereas there was no effect in the placebo group (ORQ5 versus Q1: 1.16; 95% CI: 0.82, 1.63; P for trend = 0.54). In contrast, the inverse association between apo B and SF was only observed in the placebo group (ORQ5 versus Q1: 0.52; 95% CI: 0.34, 0.81; P for trend = 0.003), whereas there was no association in the intervention group (ORQ5 versus Q1: 1.11; 95% CI: 0.75, 1.64; P for trend = 0.93).

Effects of dietary fiber from different food sources on anthropometric data, blood pressure, and biological markers in models adjusted on sex, age, alcohol-free energy intake, saturated fatty acids, carbohydrates, tobacco, alcohol, leisure-time exercise, and intervention supplement intake are described in Tables 5Go and 6Go. Fiber intakes from vegetables or legumes had no effect on BMI or the waist-to-hip ratio. Cereal fiber intake decreased the overweight risk but had no effect on waist-to-hip ratio (Table 5Go). High blood pressure risk was decreased with high intakes of fiber from cereal products and vegetables. Fiber from cereal products, vegetable, and pulses had no significant effect on any biological marker of cardiovascular disease, except for a reduced risk of high homocysteine with high fiber intakes from cereal products or vegetables.


View this table:
[in this window]
[in a new window]
  		TABLE 5 Odds ratios (and 95% CIs) for the relative risk of abnormal markers of cardiovascular disease for the fifth versus the first quintile of dietary fiber intake (g/d) from cereal products, vegetables, or legumes1

 

View this table:
[in this window]
[in a new window]
  		TABLE 6 Odds ratios (and 95% CIs) for the relative risk of abnormal markers of cardiovascular disease for the fifth versus the first quintile of dietary fiber intake (g/d) from fruit (fresh, canned, or juice), dried fruit, or nuts and seeds1

 
Fiber from fruit decreased the risk of a high waist-to-hip ratio but had no effect on BMI. We observed a marked reduction in risk associated with both a high BMI and a high waist-to-hip ratio with increasing fiber intake from dried fruit or from nuts and seeds. High blood pressure risk was decreased with high intakes of fiber from fresh and dried fruit. Fiber from fruit was not specifically associated with abnormal biological markers of cardiovascular disease risk. In contrast, fiber from dried fruit was inversely associated with high apo B, triacylglycerol, and fasting glucose concentrations (P for trend = 0.02, 0.01, and < 0.0001, respectively) and positively associated with high lipoprotein(a) (P for trend = 0.02). Fiber from nuts and seeds was associated with a reduced risk of elevated fasting apo B and glucose concentrations (P for trend = 0.03 and 0.002, respectively).


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
In this large cohort of French middle-aged men and women, we found consistent evidence of an inverse association between dietary fiber intake and several risk factors for cardiovascular disease, despite a moderate intake in line with preliminary data (19). Most of the total dietary fiber was NSF, whereas SF accounted for only a minor amount. These values are somewhat different from some European values (5, 25) but are in line with others in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort (26) and in the United States (3, 4, 27). The prevalence of abnormal risk markers was generally higher in men than in women and varied depending on the item concerned. Our data indicate that an important part of the French middle-aged population, especially men, have an elevated risk of cardiovascular disease, as in other industrialized countries.

Overweight and abdominal adiposity are known risk factors for cardiovascular disease and type 2 diabetes. Total dietary fiber intake was clearly inversely associated with elevated BMI and waist-to-hip ratio in the total cohort and by sex, which strongly suggested that a high-fiber diet helps to maintain a lower body fat mass. Two other epidemiologic studies in the United States have already provided evidence that body weight (4, 27) and waist-to-hip ratio (4) are inversely associated with total dietary fiber intake, whereas another study found no such relation (28). NSF intake had the same inverse association with these 2 variables, whereas SF intake was associated with a lower risk of high waist-to-hip ratio only. Finally, higher dietary fiber intakes from fruit, dried fruit, or nuts and seeds were associated with lower BMI and waist-to-hip ratio, whereas cereal fiber intake was associated with low BMI only. This finding is in line with recent observations that whole-grain intake was inversely associated with BMI and waist-to-hip ratio (27, 29). The mechanisms underlying such an effect of dietary fiber on body fat stores might be reduced energy intake, increased fat excretion, and reduced chylomicron concentrations after high-fiber meals (30, 31); blunted postprandial increases in insulinemia after high-fiber meals; improved insulin sensitivity; and reduced insulinemia (4).

Elevated blood pressure is another important risk factor for cardiovascular disease. We provide evidence of an inverse association of total dietary fiber intake with hypertension, an effect already reported in one cohort study on young adults in the United States (4). Such an inverse association was also found with NSF, whereas a trend was found with SF. This association of fiber with blood pressure was independent of the observed inverse association of fiber with BMI. Fiber from cereals, vegetables, and fresh or dried fruit independently showed an inverse association with elevated blood pressure. Such an association was not found in a cohort study in the United States (28) but was observed in a meta-analysis of clinical trials (32) and in a study with whole grain (29). As reviewed previously (33), the possible mechanisms involve reduction in abdominal obesity as discussed above, improvement in vascular reactivity as modulated by cereals (34) or plant phytoestrogens, and other possible mechanisms not yet elucidated.

Fasting total cholesterol is a well-known risk factor for cardiovascular disease as well as are high apo A-I (HDL main apoprotein) and apo B (LDL and VLDL main apoprotein) concentrations (35). In this study, total dietary fiber and NSF intakes were found to be inversely associated with hypercholesterolemia, whereas the highest versus the lowest SF intake was associated with a 19% reduction in hypercholesterolemia risk. Moreover, we found an inverse association of total dietary fiber, SF, and NSF intakes with elevated apo B concentrations and of total dietary fiber and NSF intakes with elevated apo B:A-I ratios, a relevant marker of cardiovascular disease risk (35). Another cohort study in young adults (4) reported a negative or positive association of dietary fiber intake with LDL cholesterol or HDL cholesterol, respectively, whereas another study in middle-aged adults reported a negative association of dietary fiber intake with the total/HDL cholesterol ratio (28). Our data are also in line with numerous clinical trials with fiber-enriched diets, as reviewed previously (13, 14). No specific fiber source was found to be inversely associated with elevated cholesterolemia, whereas fiber intakes from dried fruit or seeds and nuts were associated with a reduced risk of high apo B concentrations. Whole-grain intake was also found to be negatively associated with fasting total and LDL-cholesterol concentrations another study (29).

Elevated fasting triacylglycerols is another independent risk factor for cardiovascular disease (36). Total dietary fiber and NSF intakes were inversely associated with fasting triacylglycerols. This relation was independent of the association of fiber with BMI, which suggests some specific mechanisms. This was also observed in a cohort of young men (4) and is supported by data obtained during clinical trials (9). Dried fruit fiber intakes were specifically inversely associated with triacylglycerols. Whole-grain intake was also recently found to be negatively associated with fasting triacylglycerol concentrations in one study (29). As discussed above and reviewed previously (9), the consumption of dietary fiber or foods with a low glycemic index food or both zcan alter several steps in fat digestion and lipoprotein metabolism (30, 31, 37).

Mixed hyperlipidemia was inversely associated with total dietary fiber and NSF intakes only, eg, a 27% and 26% reduction in this syndrome was observed in the highest and the lowest quintiles of fiber intake, respectively.

Elevated fasting blood glucose is a marker of reduced insulin sensitivity, which predisposes to type 2 diabetes and, subsequently, to an increased risk of cardiovascular disease. In this study, only fiber from dried fruit or nuts and seeds was associated with a significantly reduced risk of high glycemia. McKeown et al (29) reported that whole-grain intake was inversely associated with fasting glucose concentrations. A few epidemiologic studies (4, 29) or clinical trials (38) reported an association between higher fiber intakes and improved insulin sensitivity.

Finally, homocysteine is an acknowledged risk factor for cardiovascular disease, the blood concentration of which is noticeably influenced by dietary habits (39). In a previous study (40), some of the authors of the present study reported that total dietary fiber, SF, and NSF intakes are inversely associated with fasting hyperhomocysteinemia; the relative risk was 0.5 for the highest versus the lowest fiber intakes. This effect was specifically associated with cereal and vegetable fiber intakes. The association might be partly explained by the high vitamin content of plant foods, especially folate—a known down-regulator of homocysteine concentrations. However, the effect remained after adjustment for intakes of folate, coffee, and vitamins B-6 and B12, which suggests a role for other mechanisms (9). An intervention trial in patients with coronary artery disease reported that a whole-grain diet decreased homocysteinemia by 28% and increased plasma antioxidant concentrations (41).

To our knowledge, this report is the first to show that nut and seed fiber intakes, even when low, could have beneficial effects on body weight, abdominal adiposity, apo B concentrations, and glycemia. Further studies are needed to evaluate these possible specific effects.

In conclusion, we obtained evidence of a consistent inverse association between dietary fiber intake and several risk factors for cardiovascular disease. These data thus provide a sound metabolic basis for an association between dietary fiber intake and reduced cardiovascular disease, as already shown in several epidemiologic studies (2, 3, 5-8, 25, 28, 42, 43). The ORs obtained herein for risk of cardiovascular disease, which ranged from 0.5 to 0.25, are comparable with those observed for cardiovascular events or deaths in the above-cited studies. Our observations agree well with the reported association between cardiovascular disease and a prudent (44), Mediterranean (45), or healthy pattern (46), which are characterized by a higher intake of plant foods containing dietary fiber, vitamins, antioxidants, and other potentially active phytochemicals.

An increase in the consumption of dietary fiber-rich foods, of up to 25 g total dietary fiber/d, is widely recommended to prevent pathologic conditions associated with low intakes (24, 47). Scientific evidence is needed to confirm that this intake is optimal. Our data show that total dietary fiber intakes ≥25 g provide a significantly reduced risk of elevated BMI, waist-to-hip ratio, plasma cholesterol, and hypertension—4 key cardiovascular disease risk factors. An increase in the total dietary fiber intake of 5 g/d was found to be associated with a further beneficial effect on these risk factors. These findings suggest that 25 g total dietary fiber/d is the minimum intake required to achieve a significant protective effect against cardiovascular disease; however, total dietary fiber intakes of 30-35 g/d will provide an even greater protective effect.


   ACKNOWLEDGMENTS
 
We thank Grand Moulins de Paris for helping to create a table of the dietary fiber content of foods.

DL and M-CB-R coordinated the study and wrote the manuscript. SH managed the overall SU.VI.MAX cohort study. NA, SB, and EC managed the SU.VI.MAX database and performed the statistical analyses. RP was involved in risk factor evaluation and corrected the manuscript. All authors contributed to the final report. None of the authors declared a conflict of interest.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Burkitt DP, Trowell HS. Refined carohydrate foods and disease: some implications of dietary fibre. London, United Kingdom: Academic Press, 1975.
  2. Kromhout D, Bosschieter EB, de Lezenne CC. Dietary fibre and 10-year mortality from coronary heart disease, cancer, and all causes. The Zutphen study. Lancet 1982; 2: 518–22.
  3. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996; 275: 447–51.[Abstract]
  4. Ludwig DS, Pereira MA, Kroenke CH, et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 1999; 282: 1539–46.[Abstract/Free Full Text]
  5. Pietinen P, Rimm EB, Korhonen P, et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation 1996; 94: 2720–7.
  6. Wolk A, Manson JE, Stampfer MJ, et al. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 1999; 281: 1998–2004.[Abstract/Free Full Text]
  7. Liu S, Buring JE, Sesso HD, Rimm EB, Willett WC, Manson JE. A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol 2002; 39: 49–56.[Abstract/Free Full Text]
  8. Bazzano LA, He J, Ogden LG, Loria CM, Whelton PK. Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 2003; 163: 1897–904.[Abstract/Free Full Text]
  9. Anderson JW, Hanna TJ, Peng X, Kryscio RJ. Whole grain foods and heart disease risk. J Am Coll Nutr 2000; 19: 291S–9S.[Abstract/Free Full Text]
  10. Jacobs DR Jr, Meyer KA, Kushi LH, Folsom AR. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr 1998; 68: 248–57.[Abstract]
  11. Liu S, Stampfer MJ, Hu FB, et al. Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 1999; 70: 412–9.[Abstract/Free Full Text]
  12. Jenkins DJ, Spadafora PJ, Jenkins AL, Rainey-Macdonald CG. Fibre in treatment of hyperlipidemia. In: Spiller GA, ed. Handbook of dietary fibre in human nutrition. Boca Raton, FL: CRC Press, 1993: 419–33.
  13. Lairon D. Dietary fibres: effects on lipid metabolism and mechanisms of action. EurJ Clin Nutr 1996; 50: 125–33.
  14. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999; 69: 30–42.[Abstract/Free Full Text]
  15. Fernandez ML. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol 2001; 12: 35–40.[Medline]
  16. Hercberg S, Preziosi P, Briancon S, et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study—design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin Trials 1998; 19: 336–51.
  17. Mennen LI, Bertrais S, Galan P, Arnault N, Potier dC, Hercberg S. The use of computerised 24 h dietary recalls in the French SU.VI.MAX Study: number of recalls required. EurJ Clin Nutr 2002; 56: 659–65.
  18. Feinberg M, Favier CJ, Ireland-Ripert J. Répertoire général des aliments. (General repertory of food.) Paris, France: FFN, CIQUAL, INRA, TecEtDoc, 1991 (in French).
  19. Lairon D, Bertrais S, Vincent S, et al. Dietary fibre intake and clinical indices in the French Supplementation en Vitamines et Mineraux AntioXydants (SU. VI.MAX) adult cohort. Proc Nutr Soc 2003; 62: 11–5.
  20. Prosky L, Asp NG, Schweizer TF, DeVries JW, Furda I. Determination of insoluble, soluble, and total dietary fiber in foods and food products: interlaboratory study. J Assoc Off Anal Chem 1988; 71: 1017–23.[Medline]
  21. US Department of Agriculture, US Department of Health and Human Services, ed. Dietary guidelines for Americans. Washington, DC: US Government Printing Office, 1990: 273–930.
  22. Kwiterovich PO Jr. Lipoprotein heterogeneity: diagnostic and therapeutic implications. Am J Cardiol 2002; 90: 1I–10I.
  23. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999; 99: 178–82.[Free Full Text]
  24. Martin A. Apports nutritionnels conseillés pour la population française. (Nutritional contributions advised for the French population.) Paris, France: Tec et Doc, 2001(in French).
  25. Todd S, Woodward M, Tunstall-Pedoe H, Bolton-Smith C. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality: results from the Scottish Heart Health Study. Am J Epidemiol 1999; 150: 1073–80.[Abstract/Free Full Text]
  26. Bingham SA, Day NE, Luben R, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003; 361: 1496–501.[Medline]
  27. Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 2003; 78: 920–7.[Abstract/Free Full Text]
  28. Wu H, Dwyer KM, Fan Z, Shircore A, Fan J, Dwyer JH. Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study. Am J Clin Nutr 2003; 78: 1085–91.[Abstract/Free Full Text]
  29. McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 2002; 76: 390–8.[Abstract/Free Full Text]
  30. Cara L, Dubois C, Borel P, et al. Effects of oat bran, rice bran, wheat fiber, and wheat germ on postprandial lipemia in healthy adults. Am J Clin Nutr 1992; 55: 81–8.[Abstract/Free Full Text]
  31. Lia A, Andersson H, Mekki N, Juhel C, Senft M, Lairon D. Postprandial lipemia in relation to sterol and fat excretion in ileostomy subjects given oat-bran and wheat test meals. Am J Clin Nutr 1997; 66: 357–65.[Abstract/Free Full Text]
  32. Streppel MT, Arends LR, van 't Veer P, V, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med 2005; 165: 150–6.[Abstract/Free Full Text]
  33. Anderson JW, Hanna TJ. Whole grains and protection against coronary heart disease: what are the active components and mechanisms? Am J Clin Nutr 1999; 70: 307–8.[Free Full Text]
  34. Katz DL, Nawaz H, Boukhalil J, et al. Effects of oat and wheat cereals on endothelial responses. Prev Med 2001; 33: 476–84.[Medline]
  35. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026–33.[Medline]
  36. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213–9.[Medline]
  37. Harbis A, Defoort C, Narbonne H, et al. Acute hyperinsulinism modulates plasma apolipoprotein B-48 triglyceride-rich lipoproteins in healthy subjects during the postprandial period. Diabetes 2001; 50: 462–9.[Abstract/Free Full Text]
  38. Pereira MA, Jacobs DR Jr, Pins JJ, et al. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr 2002; 75: 848–55.[Abstract/Free Full Text]
  39. Splaver A, Lamas GA, Hennekens CH. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am Heart J 2004; 148: 34–40.[Medline]
  40. Mennen LI, de Courcy GP, Guilland JC, et al. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 2002; 76: 1279–89.[Abstract/Free Full Text]
  41. Jang Y, Lee JH, Kim OY, Park HY, Lee SY. Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial. Arterioscler Thromb Vasc Biol 2001; 21: 2065–71.[Abstract/Free Full Text]
  42. Mozaffarian D, Kumanyika SK, Lemaitre RN, Olson JL, Burke GL, Siscovick DS. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA 2003; 289: 1659–66.[Abstract/Free Full Text]
  43. Oh K, Hu FB, Cho E, et al. Carbohydrate intake, glycemic index, glycemic load, and dietary fiber in relation to risk of stroke in women. Am J Epidemiol 2005; 161: 161–9.[Abstract/Free Full Text]
  44. Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr 2000; 72: 912–21.[Abstract/Free Full Text]
  45. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599–608.[Abstract/Free Full Text]
  46. Kerver JM, Yang EJ, Bianchi L, Song WO. Dietary patterns associated with risk factors for cardiovascular disease in healthy US adults. Am J Clin Nutr 2003; 78: 1103–10.[Abstract/Free Full Text]
  47. Marlett JA, McBurney MI, Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 2002; 102: 993–1000.[Medline]
Received for publication April 26, 2005. Accepted for publication August 2, 2005.




This article has been cited by other articles:


Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
D. A. Timm and J. L. Slavin
Dietary Fiber and the Relationship to Chronic Diseases
American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 233 - 240.
[Abstract] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. J Padayatty and M. Levine
Fruit and vegetables: think variety, go ahead, eat!
Am. J. Clinical Nutrition, January 1, 2008; 87(1): 5 - 7.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
P. Newby, J. Maras, P. Bakun, D. Muller, L. Ferrucci, and K. L Tucker
Intake of whole grains, refined grains, and cereal fiber measured with 7-d diet records and associations with risk factors for chronic disease
Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1745 - 1753.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C.-Y. O. Chen, P. E. Milbury, F. W. Collins, and J. B. Blumberg
Avenanthramides Are Bioavailable and Have Antioxidant Activity in Humans after Acute Consumption of an Enriched Mixture from Oats
J. Nutr., June 1, 2007; 137(6): 1375 - 1382.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. Shah, B. Adams-Huet, and A. Garg
Effect of high-carbohydrate or high-cis-monounsaturated fat diets on blood pressure: a meta-analysis of intervention trials
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1251 - 1256.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
L. J. Ignarro, M. L. Balestrieri, and C. Napoli
Nutrition, physical activity, and cardiovascular disease: An update
Cardiovasc Res, January 15, 2007; 73(2): 326 - 340.
[Abstract] [Full Text] [PDF]

Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
K. J. Melanson
Dietary Factors in Reducing Risk of Cardiovascular Diseases
American Journal of Lifestyle Medicine, January 1, 2007; 1(1): 24 - 28.
[Abstract] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Friedenreich, T. Norat, K. Steindorf, M.-C. Boutron-Ruault, T. Pischon, M. Mazuir, F. Clavel-Chapelon, J. Linseisen, H. Boeing, M. Bergman, et al.
Physical Activity and Risk of Colon and Rectal Cancers: The European Prospective Investigation into Cancer and Nutrition
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2398 - 2407.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lairon, D.
Right arrow Articles by Boutron-Ruault, M.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lairon, D.
Right arrow Articles by Boutron-Ruault, M.-C.
Agricola
Right arrow Articles by Lairon, D.
Right arrow Articles by Boutron-Ruault, M.-C.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS